*** MICK, $Pistol Pete$ & FRIENDS STOCK PICKS *** M F S P''''

[2times2]

MSRM
Mushrooms Inc. CEO, Kimberly Carlson, Discusses Exciting Potential of Industrial Mushroom Industry on Psychedelic Spotlight Podcast.
Estero, FL, July 19, 2023 – Mushrooms Inc. (OTC: MSRM) (the “Company” or “MSRM) is pleased to announce that its CEO, Kimberly Carlson, recently appeared on the esteemed Psychedelic Spotlight Podcast to discuss the exciting potential of the industrial mushroom industry. As the first company trading on the US stock market focused on the industrial side of mushrooms, Mushrooms Inc. is leading the way in revolutionizing this emerging sector.

To watch or listen to the complete interview featuring Kimberly Carlson on Psychedelic Spotlight, please visit the following link: https://psychedelicspotlight.com/using-mycelium-for-a-sustainable-future-feat-kimberly-carlson/

During the podcast episode hosted by David Flores (CEO of Psychedelic Spotlight), Kimberly Carlson shared insights into the vision and mission of Mushrooms Inc. The Company is dedicated to supporting the growth of the mushroom industry through collaboration, innovation, and development. At the heart of Mushrooms Inc. lies a commitment to creating and supporting environmentally beneficial product innovation.
With a specific focus on the industrial application of mycelium, Mushrooms Inc. aims to develop carbon-neutral products for the building, textile, and healthcare industries. By harnessing the power of mycology, Mushrooms Inc. seeks to advance the creation of scientifically proven products that promote the health of the body, mind, and environment which includes remediation of toxic substances using mycelium also known as Myco-remediation.

Along with providing Mr. Flores with an overview of Mushrooms Inc., Ms. Carlson also shared insight into her own personal passion for working within the mushroom sector and why she believes mycelium holds the potential to promote a healthier and more sustainable environment for all of society.

"The potential of the industrial mushroom sector is immense, and Mushrooms Inc. is at the forefront of driving innovation in this field," said Kimberly Carlson, CEO of Mushrooms Inc. "Through our research and development efforts, we are committed to delivering sustainable solutions that benefit not only our customers but also the planet.
I am grateful for the opportunity to have had Mushrooms Inc. featured on the Psychedelic Spotlight Podcast, and more specifically, for the opportunity to provide their audience, as well as many others following the public markets, with an initial introduction into some the exiting things we have planned for MSRM.
In the weeks and months ahead, I look forward to being able to share some of the progress we anticipate making as we strive to truly position MSRM as an industrial mushroom leader.”
Mushrooms Inc. recognizes that true innovation comes from collaboration and learning from pioneers in the field. By fostering working relationships and engaging with experts in mycology, the Company is paving the way for groundbreaking advancements in the industry.

Mushrooms Inc. (OTC: MSRM) Announces Plan for Acquisitions and Vertically Integrated Business Development by Partnering with diversified Mushroom Market LeadersPress Release | 02/23/2023
ESTERO, FL / ACCESSWIRE / February 23, 2023 / Mushrooms, Inc. (OTC PINK:MSRM) (the "Company") has been quietly making progress within this exciting multi-billion-dollar market opportunity currently being opened by new mycelium-based materials science and biotechnology.
Mushrooms Inc. is developing profitable pathways to sustain the research and development branch which is necessary to achieve viable industrial innovation in this new field.
MSRM is targeting grants specific to their goals, working with pioneers, scientists, and universities, on a global scale to develop scientifically proven products that advance health of body, mind, and environment. They have multiple proposals that they are currently reviewing for their costs to bring to market, timelines, scalability, as well as their positive financial, environmental and health impact. These proposals include a patentable process for the development of mycelium-based building supplies, a patentable process for mushroom related cosmetic and anti-aging skin products, a superfood product not currently seen in the marketplace as well as several remediation projects with new product innovation as an end result. These proposals are being assessed while keeping the progress on an off-shore lab and scientists for an evolved patentable mycelium thread.

GROWTH STRATEGY
In order to offset research costs and time on the industrial development side we are establishing pillars of development outside of the industrial mushroom market through acquisitions and joint ventures. The business model is based on the amazing qualities of mycelium and its networking capabilities as well as its ability to benefit from the network its developing.

CEO Kimberly Carlson shared, "I have been fortunate to connect with amazing pioneers and innovators in differing areas of the Mushroom Market in the US and abroad. Three realities have been consistent with the people behind the businesses and their processes. One is that this business model can bring like-minded companies together in order to benefit and fruit from a shared network under the public umbrella. Secondly, there are natural and substantial cross-points between these companies to mutually benefit from each other while growing as a whole. And the third is that there is a desire for many of these businesses to unite their expertise to others and share from a unified gain. By combining the power of shared ideals and resources through joint ventures, we can move as larger more developed companies do, but without limiting quality and compassion for social and environmental governance."

With a focus on profitability and mutually beneficial cross points, MSRM is assessing partnerships with complimentary businesses which would strategically advance the Company's reach into related markets through joint ventures and M&A activity.
Establishing pillars of development outside of the industrial mushroom market allows for a broad scope of proven profitability and cross-sharing of resources.
We seek to enter partnerships in the Cultivation Market, which includes substrate, spawn production, and fruiting. Cultivation gives life to all market pillars to some degree. It feeds directly into the Mushroom Nutraceutical and Medicinal Psylocibin Market with the addition of extraction, quality testing, product development, and processing. The Medicinal Mushroom Market requires legalization and branches into wellness retreats, treatment certifications and clinics.

MSRM is also evaluating several companies involved in the Myco-Remediation Market which uses fungi to clean oil spills, heavy metals, plastics and other pollutants from soil, water, and the atmosphere. All of these markets relate to the industrial and health innovation that the Company is pursuing in differing aspects and creates a connecting point for acceleration, mutual benefit and market share.
It is the belief of MSRM that connecting these pillars of the mushroom market through joint ventures and acquisitions, while focusing their innovation efforts on the industrial side of the market, will garner cross benefits financially and accelerate timelines during the major research and development phases.
We are simultaneously creating a vertically integrated business model for the businesses involved by aligning strengths between the companies under the umbrella of MSRM.
From an investor perspective, we are creating an avenue for investors to support a larger portion of the mushroom market, establishing a broader financial base of support for and from the networked companies while allowing for a more elastic ability to pivot, expand and connect to new industry pathways as they surface.

Market Opportunity
Mushrooms, Inc. operates in the North American segment of the functional mushroom market in the mycelium material and mushroom supplement product types. According to various industrial research firms, the global functional mushroom market is projected to show a compounded annual growth rate of over 9% for the next five years (Industry Arc and Vantage Market Research). The North American edible mushroom market was worth 11.99 billion in 2023 and is growing at a compounded annual growth rate of 9.48%, forecast to reach 20.91 billion by 2028 (Market Data Forecast). The North American functional mushroom market held 33.8% of the global market in 2020 and is growing at a compounded annual growth rate of 7% (Industry Arc).

Overview
Mushrooms, Inc. is a developing-stage emerging consumer products platform focused on the manufacturing and marketing of highly differentiated mushroom-based materials and functional supplements. The core growth pillars of the Mushrooms, Inc. platform are currently based on developing functional mushroom technologies. As a result of growing consumer demand for innovative, sustainable, and carbon-neutral products, Mushrooms, Inc. plans to grow revenues by penetrating the multi-billion-dollar market opportunity currently being opened by new mycelium-based materials science and biotechnology, as well as expanding our platform to include the creation of supplements based on the proven health benefits of mushrooms.
Mushrooms, Inc. seeks to drive the growth of the bourgeoning functional mushroom industry through product innovation and development. Our current core business activity is environmentally beneficial product innovation utilizing self-growing, fibrous, and natural composite materials with controlled physical properties that can be produced in large quantities. Our product technologies focus on mycelium, the main component of fungi. This emerging biotechnology is used in the creation of carbon neutral products for the building, textile, packaging, and health care industries, as well as in the creation of supplements based on the proven health benefits of mushrooms.

Currently, our research focuses primarily on the significant thermal stability of mycelium materials, a result of mycelium's unique degradation qualities that expand the potential fields of application for mushroom-based products. Mushrooms, Inc.'s long-term goal is to build a strong scalable and widely recognized brand that authentically focuses on sustainable mushroom ingredients and novel functionality stemming from innovative biotech and materials science.
For more information, email [e-mail] or visit www.mushroomsinc.com
07/19/2023 Mushrooms Inc. CEO, Kimberly Carlson, Discusses Exciting Potential of Industrial Mushroom Industry on Psychedelic Spotlight Podcast Press Release
02/23/2023 Mushrooms Inc. (OTC: MSRM) Announces Plan for Acquisitions and Vertically Integrated Business Development by Partnering with diversified Mushroom Market LeadersPress Release

04/20/2023 Quarterly Report for the period ended March 31, 2023
03/06/2023 Attorney Letter with Respect to Current Information - Shell Status Opinion MSRM
03/06/2023 Attorney Letter with Respect to Current Information - MSRM - Current Information Letter
03/06/2023 Annual Report - MSRM 2022 Annual Report
11/29/2022 Mushrooms, Inc. Announces Name and Ticker Symbol Change on OTC Markets to “MSRM” Press Release
https://www.otcmarkets.com/stock/MSRM/disclosure
08/23/2022 Marijuana Strategic Ventures, Inc. (OTC: MSVI) Now Mushrooms Inc., Announces Filing of Provisional Patent for Novel Mycelium Thread Press Release

Outstanding Shares 38,485,760 07/18/2023
Restricted 32,527,735 07/18/2023
Unrestricted 5,958,025 07/18/2023
Authorized Shares 400,000,000 07/18/2023

update by CEO:
see twitter https://twitter.com/MushroomsInc

MSRM This is totally under the Radar and is REAL. Check the SS , they did file a Patent that is coming up , they do have the product and their Mgt Team actually knows what they are doing.
https://otcmarkets.com/stock/MSRM/security
https://mushroomsinc.com/team-3
https://twitter.com/MushroomsInc